Table of Contents

company-logo

Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. The company offers Octapharma, a human albumin solution for use in premature infants; Axetine, which is used for the treatment of bacterial infections, including respiratory infections, urinary tract infections, soft tissue infections, gynecological and obstetrical infections, gonorrhea, and other infections, as well as for the prevention of post-surgery infections; and Medocef that is used for the treatment of bacterial infections, such as the infections of the lower respiratory tract comprising pneumonia, urinary tract, bile duct, peritoneum, skin, soft tissue, pelvic area, and sepsis. It also provides Esafosfina, which is used for treating hypophosphatemia and chronic diseases, including alcohol intoxication, malnutrition, and hypophosphatemic respiratory failure; Taurolite, a third generation oral cholic acid drug that is used for the treatment of gallstone diseases; and Tamifil injection for the treatment of metastatic prostate cancer, true precocious puberty, and endometriosis. In addition, the company engages in the sale of pharmaceutical products; and provides warehouse facilities for pharmaceutical products; and offers international trade services, as well as provides consultation services for medical and biological technology. The company was founded in 2011 and is headquartered in Chengdu, the People's Republic of China. Sinco Pharmaceuticals Holdings Limited is a subsidiary of Risun Investments Limited.

Sinco Pharmaceuticals Dividend Announcement

• Sinco Pharmaceuticals announced a annually dividend of HK$0.00 per ordinary share which will be made payable on 2024-06-04. Ex dividend date: 2024-05-20
• Sinco Pharmaceuticals annual dividend for 2024 was HK$0.00
• Sinco Pharmaceuticals annual dividend for 2023 was HK$0.01
• Sinco Pharmaceuticals's trailing twelve-month (TTM) dividend yield is 2.3%

Sinco Pharmaceuticals Dividend History

Ex-Div dateDividend amountDividend typePay date
2024-05-20HK$0.00annually2024-06-04
2023-05-31HK$0.01annually2023-06-15
2016-09-09HK$0.00annually2016-10-18

Sinco Pharmaceuticals Dividend per year

Sinco Pharmaceuticals Dividend Yield

Sinco Pharmaceuticals current trailing twelve-month (TTM) dividend yield is 2.3%. Interested in purchasing Sinco Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Sinco Pharmaceuticals Financial Ratios

P/E ratio7.39
PEG ratio-0.48
P/B ratio0.53
ROE7.33%
Payout ratio0.00%
Current ratio1.18
Quick ratio1.14
Cash Ratio0.25

Sinco Pharmaceuticals Dividend FAQ

Does Sinco Pharmaceuticals stock pay dividends?
Sinco Pharmaceuticals does not currently pay dividends to its shareholders.
Has Sinco Pharmaceuticals ever paid a dividend?
No, Sinco Pharmaceuticals has no a history of paying dividends to its shareholders. Sinco Pharmaceuticals is not known for its dividend payments.
Why doesn't Sinco Pharmaceuticals pay dividends?
There are several potential reasons why Sinco Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Sinco Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Sinco Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Sinco Pharmaceuticals a dividend aristocrat?
Sinco Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Sinco Pharmaceuticals a dividend king?
Sinco Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Sinco Pharmaceuticals a dividend stock?
No, Sinco Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Sinco Pharmaceuticals stocks?
To buy Sinco Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Sinco Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.